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Abstract
For the past five years, genome-wide association studies (GWAS) have identified hundreds of common variants associated
with human diseases and traits, including high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), and triglyceride (TG) levels. Approximately 95 loci associated with lipid levels have been identified primarily among
populations of European ancestry. The Population Architecture using Genomics and Epidemiology (PAGE) study was
established in 2008 to characterize GWAS–identified variants in diverse population-based studies. We genotyped 49 GWAS–
identified SNPs associated with one or more lipid traits in at least two PAGE studies and across six racial/ethnic groups. We
performed a meta-analysis testing for SNP associations with fasting HDL-C, LDL-C, and ln(TG) levels in self-identified
European American (,20,000), African American (,9,000), American Indian (,6,000), Mexican American/Hispanic (,2,500),
Japanese/East Asian (,690), and Pacific Islander/Native Hawaiian (,175) adults, regardless of lipid-lowering medication use.
We replicated 55 of 60 (92%) SNP associations tested in European Americans at p,0.05. Despite sufficient power, we were
unable to replicate ABCA1 rs4149268 and rs1883025, CETP rs1864163, and TTC39B rs471364 previously associated with HDL-
C and MAFB rs6102059 previously associated with LDL-C. Based on significance (p,0.05) and consistent direction of effect, a
majority of replicated genotype-phentoype associations for HDL-C, LDL-C, and ln(TG) in European Americans generalized to
African Americans (48%, 61%, and 57%), American Indians (45%, 64%, and 77%), and Mexican Americans/Hispanics (57%,
56%, and 86%). Overall, 16 associations generalized across all three populations. For the associations that did not generalize,
differences in effect sizes, allele frequencies, and linkage disequilibrium offer clues to the next generation of association
studies for these traits.
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Introduction
Since its introduction in 2005, the genome-wide association
study (GWAS) design has become a powerful tool in human
genetics to identify single nucleotide polymorphisms (SNPs) asso-
ciated with common diseases or traits using an experimental
design that does not require a priori biological knowledge. As of
September 2010, greater than 1,000 SNPs across the genome have
been reported as genome-wide significant (p#5610
28) for 165
traits [1]. An early analysis of the GWAS-reported SNPs demon-
strated that most identified variants were intergenic or intronic [2],
suggesting either novel biology or that the functional variant has
yet to be found.
While GWAS have been successful in identifying novel asso-
ciations, there are several limitations. First, the majority of GWAS
have been conducted in populations of European-descent. There
are several GWAS in populations of Asian-descent, and GWAS
are just emerging for other populations such as African Americans
[3–20], Mexican Americans/Hispanics [9,20–26], and American
Indians [27]. It is possible that novel associations await discovery
in these populations given the differing linkage disequilibrium (LD)
patterns when compared with populations of European-descent
[28]. Second, much work is needed to test SNPs discovered in
case-control studies in more population-based, representative
cohorts to determine if the associations generalize. Data on gen-
eralization will inform future fine-mapping [29] and discovery
studies as well as provide clues to whether GWAS-identified SNPs
are simply tagSNPs or are more likely to be true functional SNP(s).
A major goal of the Population Architecture using Genomics
and Epidemiology (PAGE) study is to determine whether GWAS-
identified variants generalize to diverse groups drawn from popu-
lation-based studies [30]. Generalization is defined here as a
significant association (p,0.05, uncorrected for multiple testing) in
a non-European population and a direction of genetic effect in the
same direction as that of European Americans. In PAGE, variants
identified in GWAS and well replicated in multiple studies are
chosen for targeted genotyping in hundreds to thousands of Euro-
pean Americans (,20,000), African Americans (,9,000), Amer-
ican Indians (,6,000), Mexican Americans/Hispanics (,2,500),
Japanese/East Asians (,690), and Native Hawaiians/Pacific
Islanders (,175). All samples are linked to extensive demographic,
health, and exposure data, making the PAGE study a rich resource
for post-discovery generalization and characterization for common
human diseases and traits.
We present here PAGE study data on the replication and
generalization for 49 SNPs associated with three common lipid
traits: low-density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C), and triglycerides. Each of these
three traits has numerous GWAS published in European ancestry
individuals [30–43] but only a handful published in other popu-
lations (such as Asians [44] and Micronesians [45]). Additional
data are just now emerging from large sample sizes of diverse
populations for generalization [32,46–51] and fine-mapping [52]
of these lipid GWAS-identified SNPs. We demonstrate that the
majority of the targeted GWAS-identified SNPs replicate in Euro-
pean Americans in PAGE and that many generalize to diverse
populations. Both power and LD are explored as explanations of
non-generalization, highlighting the complexities involved in pro-
perly interpreting results of even robust genetic associations such
as these.
Results
Study population characteristics
The PAGE study sites are diverse across multiple variables
(Table 1 and Table S1). Together, the PAGE study consists of
several populations: European Americans, African Americans,
Mexican Americans/Hispanics, American Indians, Japanese/East
Asians, and Native Hawaiians/Pacific Islanders. All PAGE study
sites except WHI ascertained both men and women. Participant
age varies widely across PAGE. For example, CHS ascertained on
average older adults (median age =74 and 72 years for Euro-
pean and African Americans, respectively), CARDIA ascertained
younger adults (median age =26 and 24.5 years for European and
African Americans, respectively), and NHANES ascertained all
ages of adults (18 years to 90 years; median age =51, 39, and 40
years for European, African, and Mexican Americans, respective-
ly). In addition to demographic differences, lifestyles and health
differed across the PAGE study sites by population, including
lipid lowering medication use and current smoking status. More
Japanese participants ascertained by MEC reported lipid lowering
medication use compared with other populations ascertained by
other PAGE study sites: 38.3% versus ,5–10%. American Indians
from the Dakotas reported more smoking (42.2–47.8%) than other
American Indians (25–33%) or other PAGE study site populations
(6.3% to 35.3%). The differences in demographics, lifestyle, and
health characteristics observed across the PAGE study sites and
populations are reflected in the three traits studied here (Table S1).
Given the diversity observed across the PAGE study sites, we
performed all tests of association for HDL-C, LDL-C, and
triglycerides unadjusted, minimally adjusted (for age and sex), and
adjusted for various demographic, lifestyle, and health variables.
Genetics of Lipid Traits in PAGE
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Coded allele frequencies are presented in Table 2, Table 3,
Table 4 and in Figure S1, by population. We calculated the
Pearson correlation coefficient (r) and FST between European
American coded allele frequencies and all other groups. The
highest correlation was observed in the comparison with Mexican
Americans/Hispanics (0.97) followed by American Indians (0.92),
Native Hawaiians/Pacific Islanders (0.90), Japanese/East Asians
(0.87), and African Americans (0.84). Compared with European
Americans, the proportion of SNPs with FST values greater than
0.15 was smallest in Mexican Americans/Hispanics (0/49 SNPs)
and largest in African Americans (6/49 SNPs; 12%) followed by
Japanese/East Asians (5/46 SNPs, 11%). FST values were small for
the remaining populations compared to European Americans,
with 3% and 7% of SNPs with FST values greater than 0.15 for
American Indians and Native Hawaiians/Pacific Islanders,
respectively.
A striking example of population differences in allele frequencies
is FADS1 rs174547. The T allele of FADS1 rs174547 is the major
allele in three populations (allele frequency =0.66, 0.91, and 0.59
in European Americans, African Americans, and Japanese/East
Asians, respectively), but is the minor allele in the other three
populations (allele frequency =0.39, 0.21, and 0.42 in Mexican
Americans/Hispanics, American Indians, and Native Hawaiians/
Pacific Islanders, respectively). Compared to European Americans,
FST for this SNP was largest in American Indians (0.34) followed
by African Americans (0.15).
We also compared allele frequencies between the various PAGE
study sites, within each racial/ethnic group. As demonstrated in
Figure S2, the allele frequencies of European Americans, African
Americans, and Mexican Americans/Hispanics do not differ
substantially across PAGE studies (allele frequencies differ by less
than 60.10). In contrast, over half of the SNPs genotyped in
American Indians had allele frequency differences greater than
60.10, with three SNPs with allele frequencies that differed by
more than 60.25. Comparisons are more difficult in Japanese/
East Asians and Native Hawaiians/Pacific Islanders, as many
SNPs were genotyped by only one PAGE study in these two
racial/ethnic groups.
Replication in European-descent populations
We meta-analyzed tests of association for 27, 19, and 14 SNPs
previously associated with HDL-C, LDL-C, and/or triglycerides,
Table 1. Characteristics of PAGE study populations.
EAGLE MEC WHI CALiCo
ARIC CARDIA CHS SHS
Type of Study Cross-sectional NestedCase
Control
Cohort and
Clinical Trials
Longitudinal Longitudinal Longitudinal Longitudinal
Focus of Cohort N/A Cancer* Women’s
Health
Cardiovascular
Disease
Cardiovascular
Disease
Cardiovascular
Disease
Cardiovascular
Disease
Years Collected 1991–1994,
1999–2002
1993–1996 1993–1998 1987–2007 1986–2006 1989–1999 1988–present
Median Age 43 67 63 54 25 73 47
Age Range 18–90 48–86 50–79 44–66 18–35 64–96 14–93
% Women 54 36 100 57 56 62 59.3
Race/Ethnicity(nmax)
European Americans 3,909 317 4,688 11,178 2,134 2,787 –
African Americans 1,896 552 1,840 3,770 2,035 550 –
American Indians – – 113 – – – 6,021
Mexican Americans 2,361 299 762 – – – –
Japanese/East Asian – 576 251 – – – –
NativeHawaiian/PacificIslander – 87 113 – – – –
*Only controls (cancer-free participants) from the overall nested case-control study were included in this lipids study.
Epidemiologic Architecture for Genes Linked to Environment (EAGLE); Multiethnic Cohort (MEC); Women’s Health Initiative (WHI); Causal Variants Across the Life Course
(CALiCo); Atherosclerosis Risk in Communities (ARIC); Coronary Artery Risk Development in Young Adults (CARDIA); Cardiovascular Health Study (CHS); Strong Heart
Study (SHS).
doi:10.1371/journal.pgen.1002138.t001
Author Summary
Low-density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels
are well known independent risk factors for cardiovascular
disease. Lipid-associated genetic variants are being dis-
covered in genome-wide association studies (GWAS) in
samples of European descent, but an insufficient amount
of data exist in other populations. Therefore, there is a
strong need to characterize the effect of these GWAS–
identified variants in more diverse cohorts. In this study,
we selected over forty genetic loci previously associated
with lipid levels and tested for replication in a large
European American cohort. We also investigated if the
effect of these variants generalizes to non-European
descent populations, including African Americans, Amer-
ican Indians, and Mexican Americans/Hispanics. A majority
of these GWAS–identified associations replicated in our
European American cohort. However, the ability of
associations to generalize across other racial/ethnic
populations varied greatly, indicating that some of these
GWAS–identified variants may not be functional and are
more likely to be in linkage disequilibrium with the
functional variant(s).
Genetics of Lipid Traits in PAGE
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individual PAGE study sites (Table S2). For HDL-C, 23 of the 27
(85%) SNPs tested were associated at p,0.05 assuming an
additive genetic model and adjusting for age and sex (Figure 1
and Table 2). The four SNPs that did not replicate at this liberal
significance threshold were rs471364 (TTC39B), rs1883025
(ABCA1), rs4149268 (ABCA1), and rs1864163 (CETP), all of
which are intronic (Table S2). For LDL-C, only one (intergenic
MAFB rs6102059) of the 19 SNPs tested was not significantly
associated at p,0.05 (Figure 1 and Table 3). Finally, for ln(TG),
all 14 SNPs tested were associated at p,0.05 (Figure 1 and
Table 4).
Figure 1. Meta-analysis results for GWAS–identified SNPs by population. Each SNP was tested for an association with the indicated trait
assuming an additive genetic model adjusted for age and sex. Meta-analysis was performed, and p-values (2log10 transformed) of the meta-analysis
are plotted along the y-axis using Synthesis-View [73,74]. SNP location is given on the x-axis. Each triangle represents a meta-analysis p-value for each
population. Populations are color-coded as follows: European Americans (blue; EA), African Americans (red; AA), Mexican Americans/Hispanics
(orange; MA/H), and American Indians (purple; AI). Large triangles represent p-values at or smaller than genome-wide significance (p,10
28). The
direction of the arrows corresponds to the direction of the beta coefficient. The significance threshold is indicated by the red bar at p=0.05.
doi:10.1371/journal.pgen.1002138.g001
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descent populations from PAGE, four out of five had sufficient
power (.80%) to detect the previously reported effect size:
TTC39B rs471364 (.99% power; HDL-C), CETP rs1864163
(80% power; HDL-C); MAFB rs6102059 (.90% power; LDL-C),
and ABCA1 rs4149268 (99% power; HDL-C). ABCA1 rs1883025,
which did not replicate the expected association with HDL-C, did
not have sufficient power to detect the reported effect size (68%
power; n=3,865).
We then compared the genetic effect sizes reported in the
literature to the genetic effect sizes estimated from the meta-
analysis of these population-based studies. We observed that the
majority of the point estimates of effect size (b) were smaller than
previously reported estimates. Using the HDL-C association
results as an example, 15 out of the 23 (65%) significant associa-
tions had effect estimates smaller than published effect estimates.
We caution, however, that we did not formally test for significant
differences between estimates and that these smaller effect esti-
mates may or may not be significantly different than the published
reports. However, it is interesting to note that 11 of our effect
estimates differed from previous reports by more than 25%,
including two HDL-C associations whose effect sizes differed by
50% or more from those in the literature (ANGPTL4 rs2967605
and MLXIPL rs17145738; Table 2 and Table S2).
Associations in non-European–descent populations
We meta-analyzed tests of association performed in African
Americans for the same 27, 19, and 14 SNPs previously associated
with HDL-C, LDL-C, and/or triglycerides in populations of
European-descent. For all three traits studied, assuming an addi-
tive genetic model and adjusting for age and sex, approximately
half of the tested GWAS-identified SNPs were associated at
p,0.05: 12/27 (44%) for HDL-C, 11/19 (58%) for LDL-C, and
8/14 (57%) for ln(TG) (Figure 1, Figure S3, Table 2, Table 3,
Table 4, Table 5). The majority of SNPs that failed to replicate in
the meta-analysis for European Americans also failed to associate
in the meta-analysis for African Americans. Interestingly, one SNP
(CETP rs1864163) was significantly associated with HDL-C in
African Americans (n=451; CAF=0.27; b=22.79; p=6.19610
23)
but not in European Americans (n=291; CAF=0.23; b=22.07;
p=0.13).
Other populations that were examined for select SNPs included
American Indians, Mexican Americans/Hispanics, Japanese/East
Asians, and Native Hawaiians/Pacific Islanders. Among American
Indians, 9/21 (43%), 10/14 (71%), and 10/13 (77%) of the SNPs
tested for association with HDL-C, LDL-C, and ln(TG), respec-
tively, were associated at the liberal significance threshold of
p,0.05. For Mexican Americans/Hispanics, 14/27 (52%), 10/19
(53%), and 12/14 (86%) SNPs were significantly associated at
p,0.05 with HDL-C, LDL-C, and ln(TG), respectively. Despite a
small sample size, intronic CETP rs1864163 was significantly
associated with HDL-C in Mexican Americans/Hispanics (n=
265; CAF=0.28; b=22.98; p=1.78610
22) but not in European
Americans (n=291; CAF=0.27; b=22.07; p=0.13), although
the size and the direction of effect were similar. Venn diagrams
representing the overlap of significant associations across the four
major PAGE populations are presented in Figure S3.
The sample sizes for Japanese/East Asians and Native Hawai-
ians/Pacific Islanders are considerably smaller compared with the
other populations examined. Despite the lower power to detect
associations, significant associations were observed for both groups
at a liberal significance threshold of p,0.05. Among the 26, 18,
and 13 SNPs tested for associations with HDL-C, LDL-C, and
ln(TG), respectively, there were nine (35%), three (17%), and three
(23%) SNPs significantly associated in the combined Japanese/
East Asian group.
For Native Hawaiians/Pacific Islanders, the group with the
smallest sample size considered here, one SNP each was associated
with HDL-C (APOA1/C3/A4/A5 gene cluster rs28927680) and
LDL-C (APOB rs754523) out of the 24 and 18 SNPs tested for
association, respectively. Three out of 12 SNPs tested for an
association with ln(TG) were associated at p,0.05 (PLTP rs7679,
MLXIPL rs17145738, and APOA1/C3/A4/A5 gene cluster rs289
27680), with the latter at a significance of p,10
219.
Generalization across non-European–descent populations
For the 55 SNP-trait associations that replicated in European
Americans, we determined which associations generalized across all
Table 5. Observed versus expected number of significant associations, by trait and population.
Trait Race/Ethnicity
# of Total Tests
of Association*
# of Observed
Significant Associations
# of Expected Significant
Associations
{ P-value
{
HDL-C AA 23 11 17.3 0.01
AI 20 9 14.4 0.01
MA/H 23 13 13.8 0.83
LDL-C AA 18 11 14.7 0.03
AI 14 10 11.9 0.15
MA/H 18 10 10.6 0.81
ln(TG) AA 14 8 11.9 0.01
AI 13 10 8.4 0.56
MA/H 14 12 10.4 0.54
The expected number of significant associations was based on power calculations assuming an additive genetic model and liberal significance threshold (0.05) in each
racial/ethnic group for each test of association. We further assumed the observed genetic effect size (beta) from PAGE European Americans and the observed allele
frequency, sample sizes, and trait mean/standard deviations from each non-European American population.
*Only includes associations that replicated in EA.
{Based on the additive power of all loci.
{One-sample binomial test.
African Americans (AA); American Indians (AI); Mexican Americans/Hispanics (MA/H); number (#).
doi:10.1371/journal.pgen.1002138.t005
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Americans, American Indians, and Mexican Americans/Hispanics).
Generalization was based on two criteria: 1) level of significance (i.e.
p-value) and 2) direction of effect (i.e. positive or negative beta).
SNPs that were significantly associated at p,0.05 and had the same
direction of effect as European Americans in all populations studied
were considered to have generalized. For HDL-C, five SNPs (CETP
rs3764261, LPL rs6586891, LIPC rs4775041, LPL rs2197089, and
APOA1/C3/A4/A5 gene cluster rs3135506) met these criteria, and
two SNPs (LCAT rs2271293 and LPL rs328) were associated in three
groups and trended towards significance in a fourth group (p=0.06
and p=0.07 in Mexican Americans/Hispanics and American
Indians, respectively; Table 2).
For LDL-C, six SNPs generalized across all four groups, if
genotyped: APOB rs562338, CELSR2/PSRC1/SORT1 rs599839
and rs646776, PCSK9 rs11591147, HMGCR rs12654264, and
LDLR rs2228671 (Table 3). Similarly for ln(TG), six SNPs were
significantly associated across the four largest populations: APOA1/
C3/A4/A5 gene cluster rs964184 and rs3135506, GCKR rs780094,
LPL rs328, MLXIPL rs1714573, and FADS1 rs174547. In addition,
for ln(TG), two SNPs (LPL rs2197089 and GCKR rs1260326) were
associated in three groups and trended towards significance in a
fourth group (p=0.07 in African Americans and p=0.09 in
American Indians, respectively). Among the 17 SNPs that gen-
eralized across the largest groups among the three lipid traits,
only four (24%) were either nonsense (rs328) or missense SNPs
(rs3135506, rs11591147, and rs1260326; Table S2).
Power
Based on our definition of generalization, several SNPs dis-
covered and replicated in European-descent populations failed to
generalize to other populations. There are several possible explana-
tions fornon-generalization, including power.To further investigate
potential lack of power, we first performed post-hoc power calcu-
lations assuming an additive genetic model and liberal significance
threshold (0.05) in each racial/ethnic group for each test of associa-
tion. In these power calculations, we further assumed the observed
genetic effect size (beta) from PAGE European Americans and the
observed allele frequency, sample sizes, and trait mean/standard
deviations from each non-European American population. By adding
the power of all tested loci, we estimated the number of expected
significant associations and compared this to the number of observed
significant associations (Table 5).
In general, the number of expected significant associations was
greater than the number observed. African Americans consistently
had fewer significant associations (11, 11, and 8 for HDL-C, LDL-
C, and ln(TG), respectively) than expected (17.3, 14.7, and 11.9
for HDL-C, LDL-C, and ln(TG), respectively) based on power,
regardless of the lipid trait being tested. More specifically, we were
powered to detect in African Americans 17 of the 25 associations
that replicated in European Americans but failed to generalize to
African Americans.
Compared to African Americans, differences between the
observed and the expected number of associations for American
Indians and Mexican Americans/Hispanics were less extreme. In
fact, for ln(TG), more significant associations were detected in these
two populations than the PAGE study was powered to detect (8.4
and 10.4 expected; 10 and 12 observed for American Indians and
Mexican Americans/Hispanics, respectively; Table 5). We were
powered to detect in American Indians nine of the 18 associations
that replicated in European Americans but did not generalize to
American Indians. Similarly, we were powered to detect in
Mexican Americans/Hispanics eight of the 20 associations that
replicated in European Americans but failed to generalize to
Mexican Americans/Hispanics.
Linkage disequilibrium
To examine whether LD can account for the lack of gen-
eralization of the properly powered tests of association in African
Americans, we examined LD patterns in HapMap Europeans
(CEU) and West Africans (YRI) as well as those published in the
literature for the genotyped SNPs and surrounding variation. For
APOA1/C3/A4/A5 rs28927680, previous studies in European-
descent populations have noted that this SNP is in strong LD
(r
2=0.98) with missense APOA5 rs3135506 [42]. APOA1/C3/A4/
A5 rs964184 is also in moderate LD with missense rs3135506
(r
2=0.510 in CEU). However, neither rs28927680 nor rs964184
are in LD with missense rs3135506 (r
2=0.039 and r
2=0.048) in
YRI. Furthermore, APOA5 rs3135506 is associated with HDL-C
in European Americans, African Americans, Mexican Americans/
Hispanics, and American Indians (Table 1 and Table 2). Gen-
eralization of rs3135506 coupled with non-generalization and
differences in YRI LD patterns for rs28927680 and rs964184
suggest that APOA5 rs3135506 is either the putative functional
SNP for the association with HDL-C or in LD with the functional
SNP. Although the exact mechanism is not yet known, molecular
modeling [53] as well as in vitro [53] and in vivo [54,55] studies
support the epidemiologic evidence that rs3135506 is functional.
Other interpretations of LD patterns are more difficult. For
example, CETP rs9989419, which failed to generalize in African
Americans for HDL-C despite sufficient power, is not in strong LD
with obvious functional SNPs in CEU within 50 kb flanking the
genotyped SNP. The strongest pair-wise LD (r
2=0.251) consists of
intergenic and intronic SNPs, and these same SNPs have weak LD
(r
2,0.03) or are not found in YRI. Similarly, LIPC rs261332
associated with HDL-C levels in European Americans but failed to
generalize in African Americans. LIPC rs261332 is in strong LD
(r
2.0.80 in CEU) with SNPs in the 59 flanking region of LIPC, but
not in LD with these same SNPs in YRI (r
2,0.15).
Adjustments for exposures and co-morbidities
Genetic variations in isolation are not the sole determinants of
lipid trait distributions. Many environmental exposures and
demographic variables are associated with lipid traits. To account
for these variables, we meta-analyzed all tests of association for
HDL-C, LDL-C, and ln(TG) adjusted for age, sex, body mass
index, current smoking, type 2 diabetes, post-menopausal status,
and current hormone use. Adjustment for these additional cova-
riates did not appreciably alter the results compared with the
models minimally adjusted for age and sex (Figures S4, S5, S6).
Inclusion of previous myocardial infarction as a variable to the
fully adjusted model also did not appreciably alter the results
compared with the minimally adjusted models (Figures S4, S5, S6).
Effect of including versus excluding by medication use
All analyses presented thus far include fasting adult participants
regardless of lipid lowering medication use. Many GWAS con-
ducted for the lipid traits excluded participants on lipid lowering
medication [40,42,43] given that these medications substantially
lower LDL-C levels. We have included these participants for
analysis as participants on lipid lowering medication could repre-
sent the upper extreme of the normal LDL-C distribution asso-
ciated with a genetic profile found in a general population. Exclu-
sion of these participants would preclude these meta-analyses from
fully describing the extent and strength of associations relevant to
these traits in a population-based setting. However, if genetic
Genetics of Lipid Traits in PAGE
PLoS Genetics | www.plosgenetics.org 9 June 2011 | Volume 7 | Issue 6 | e1002138variation is associated with lipid concentrations and medication
use lowers lipid concentrations, inclusion of participants on lipid
lowering medications could bias associations towards the null. As a
sensitivity analysis, WHI used detailed medication data available
on a subset of participants, and performed the tests of association
for HDL-C, LDL-C, and ln(TG) excluding and including parti-
cipants on lipid lowering medication with the latter adjusted for
medication usage using average effects estimated in Wu et al [56]
for specific drug classes. Figure S7 suggests that both the point
estimates and the confidence intervals of the genetic effects are
similar for this female-only study whether participants are ex-
cluded or included and adjusted for medication use.
We also performed a second sensitivity analysis: tests of
association excluding participants on lipid lowering medication
for all models. As detailed in Figures S8, S9, S10, excluding parti-
cipants on lipid lowering medication usage does not appreciably
alter the results, with the possible exception of LDL-C associations
in Japanese/East Asians. More specifically, two SNPs (rs11206510
and rs1501908) became significantly associated with LDL-C after
excluding participants on medications while two other SNPs
(rs562338 and rs6544713) were no longer significantly associated
(Figure S9). The difference in significance for these four tests of
association may be related to lipid lowering medication use;
however, it is more likely due to statistical fluctuations from small
samples sizes (nInclude=690; nExclude=467). Also of note, use of
lipid-lowering medications was low (,10%) in the ARIC, CHS,
NHANES, and WHI studies since the majority of study recruit-
ment occurred before the introduction or widespread use of the
recent generation of lipid-lowering medications. Medication use
was higher in the MEC study (20–38% depending on the popu-
lation), which contributed the majority of Japanese/East Asian
samples.
Discussion
We have performed an extensive replication and generalization
effort for HDL-C, LDL-C, and TG GWAS-identified SNPs. The
PAGE study consists of six racial/ethnic groups: European Ameri-
can, African American, Mexican American/Hispanic, American
Indian, Japanese/East Asian, and Native Hawaiian/Pacific Island-
er, with population-specific sample sizes ranging from ,100 to
.20,000 for any one test of association. Although power to detect
associations varied across the lipid traits and populations, we
observed general patterns worth noting for future genetic epide-
miological studies.
Replication in European-descent populations
Perhaps not unexpectedly, we were able to replicate most
reported associations in European Americans. Regardless of sig-
nificance, all but one of the tested SNPs had effect estimates in the
same direction as the previously reported association from the
literature. FADS1 rs174547, which was significantly associated
with decreased ln(TG) in this meta-analysis for European Ameri-
cans, was associated with increased TG in European Americans
from the Framingham Heart Study (n=7,423) [43]. HDL-C had
proportionally (15%) the greatest number of SNPs that failed to
replicate in European Americans compared with LDL-C (5%) and
TG (0%) despite the fact that we had sufficient power to detect the
reported genetic effect size for many of these tests. TTC39B
rs471364 was not associated with HDL-C levels despite a sample
size of 18,089 and .99% power to detect the reported effect size.
Neither ABCA1 rs4149268 nor rs1883025 was associated with
HDL-C, although the latter test of association was underpowered
(68%; n=3,865). Finally, as previously discussed, CETP rs186
4163 was not associated with HDL-C in this European American
dataset although we had 80% power to detect the reported genetic
effect size. For LDL-C, only MAFB rs6102059 was not associated
despite .90% power to detect the reported effect size.
The reasons for non-replication in this European American
dataset for properly powered tests of association are unclear. It is
possible that we have overestimated our power to detect reported
associations. The ‘‘winner’s curse’’ and inflated genetic effect
estimates from initial discovery are well known [57,58]. Indeed, for
the five SNPs that did not replicate in this meta-analysis for
European Americans, the association was described in only one
GWAS each despite the fact that numerous GWAS [31,33–43]
and a large meta-analysis [32] for these three traits have been
conducted in populations of European-descent. The meta-analysis
recently reported by Teslovich et al [32] did report significant
associations between TTC39B rs581080 for HDL-C and MAFB
rs2902940 for LDL-C. TTC39B rs581080 is in moderate linkage
disequilibrium (LD) with rs471364 (r
2=0.49 in CEU HapMap),
but MAFB rs2902940 is not in LD with rs6102059 (r
2=0.03 in
HapMap CEU).
A second possibility for our observed non-replication is het-
erogeneity among the PAGE studies. Because it is important to
understand the degree to which associations are consistent across
individual studies, we compared directions of effect (betas) across
PAGE study sites for each test of association (Figures S11, S12,
S13) and performed tests of heterogeneity. Association results for
TTC39B rs471364, which meta-analysis result for HDL-C in
European Americans was insignificant, had significant evidence
for heterogeneity across studies (pheterogeneity=0.048; I
2=58.25%).
In four of the five PAGE study sites, the association between this
SNP and HDL-C had consistent directions of effect; however, only
one test of association was significant in European Americans
(p=0.005 in EAGLE; Figure S11). Only two other association
results had evidence for heterogeneity among European Ameri-
cans: FADS1 rs174547 for HDL-C (pheterogeneity=0.006; I
2=
75.73%) and PCSK9 rs11206510 for LDL-C (pheterogeneity=0.048;
I
2=55.34%). However, for both of these loci, the tests of
association were significant in European Americans and had
similar directions of effect in all but one of the PAGE study sites
(Figures S11 and S12).
Generalization to non-European populations
When taking into account power, significance, and direction of
effect, most SNPs discovered in European Americans generalized
to African Americans, Mexican Americans, and American Indians.
Of note are the eleven tests of association significant in European
Americans that did not generalize to African Americans despite
having adequate power. Given that GWAS products are a mixture
of tagSNPs and functional SNPs, it is likely that discovery in
European Americans represents tagSNPs rather than the true
functional SNP. Because linkage disequilibrium patterns differ
across populations, tagSNPs genotyped directly in populations
of non-European descent may not recapitulate the association
observed in European-descent populations depending on the
pattern of LD. The association of HDL-C and nonsynonymous
rs3135506 versus tagSNPs rs28927680 in the APOA1/C3/A4/
A5gene cluster in this analysis is an example of the effects of LD and
the ability to generalize across populations.
Evoking LD as an explanation for lack of generalization is
appealing, but it does have limitations given that the functional
SNP is not often obvious. All tests of association that did not
generalize to African Americans had evidence of LD differences
between CEU and YRI using the HapMap data. However, most
of these SNPs are located in the intergenic and intronic regions.
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other diverse populations will be needed along with a better
understanding of genetic variation and its relationship to biological
function to identify the true functional SNPs for these traits.
Among the five putative functional SNPs genotyped (nonsynon-
ymous rs11591147, rs1260326, rs3135506, and rs1800961 and
nonsense rs328), all five replicated in populations of European-
descent, and three of the five generalized to populations of non-
European descent. One putative functional SNP that did not
replicate across populations was HNF4A rs1800961, likely due to
low power because of the very low minor allele frequency in all
subpopulations (0.0065 to 0.0398). Both the direction and mag-
nitude of effect, however, were consistent across groups. GCKR
rs1260326 did not generalize to all populations of non-European
descent but did generalize in three of the four populations tested
and trended towards significance in American Indians (p=0.085;
Table 4).
Limitations and strengths
The major strengths and limitations of the PAGE study for
lipids are sample size and diversity. The largest sample size is for
samples of European-descent (,20,000), followed by African
Americans and American Indians. The sample sizes for Mexican
Americans, Japanese/East Asians, and Pacific Islanders/Native
Hawaiians are smaller and consequently underpowered for tests of
association as estimated from genetic effect sizes in the published
European-descent discovery studies. Also, not all SNPs were
genotyped in all PAGE studies, further affecting the power of the
meta-analyses.
An additional limitation is the lack of data related to lipid
lowering medication. Ideally, all analyses would be adjusted for
use of lipid lowering medication based on the type and dose of
medication. In most PAGE studies, these data were not available
and in many, use was low at baseline when blood samples were
obtained. As we demonstrate in Supplementary material, inclusion
of participants using lipid-lowering medication did not appreciably
alter the results of the meta-analysis when compared with
excluding these participants. While this finding may be useful for
future studies, we caution that the majority of participants in this
study were not on lipid lowering medications.
In general, the cohorts and surveys included in PAGE are
diverse with regard to demographics, genetic ancestry, lifestyle,
health, and environmental exposure. Despite this diversity, very
few tests of association from the meta-analysis exhibited evidence
of heterogeneity.
Conclusions
Overall, the majority of GWAS-identified SNPs for HDL-C,
LDL-C, and TG replicated in European Americans and genera-
lized to non-European-descent populations. These results suggest
that the genotyped SNP either tags the functional SNP(s) common
across these populations or that the genotyped SNP represents the
risk SNP directly. SNPs that replicated in European Americans
but did not generalize in the largest non-European-descent popu-
lations, despite adequate power, could represent priority associa-
tions that require fine-mapping and re-sequencing to identify the
functional variant(s).
Materials and Methods
Study populations and phenotypes
All studies were approved by Institutional Review Boards at their
respective sites (details are given in Text S1). PAGE study samples
were drawn from four large population-based studies or consortia:
EAGLE (Epidemiologic Architecture for Genes Linked to Envi-
ronment), based on three National Health and Nutrition Exami-
nation Surveys (NHANES) [59–61], the Multiethnic Cohort (MEC)
[62], the Women’s Health Initiative (WHI) [63,64], and Causal
Variants Across the Life Course (CALiCo), a consortium of several
cohort studies: Atherosclerosis Risk in Communities Study (ARIC)
[65], Coronary Artery Risk in Young Adults (CARDIA) [66],
Cardiovascular Health Study (CHS) [67], Strong Heart Family
Study (SHFS) [68], and Strong Heart Cohort Study (SHS) [69]
(Table 1). The PAGE study design is detailed in Matise et al [30].
Serum HDL-C, triglycerides, and total cholesterol were mea-
sured using standard enzymatic methods. LDL-C was calculated
using the Friedewald equation [30,70], with missing values assigned
for samples with triglyceride levels greater than 400 mg/dl. For
PAGE study sites with longitudinal data, the baseline measurement
was used for analysis. A full description of each study, along with
population-specificstudycharacteristics, ispresented inText S1and
Table S1.
SNP selection and genotyping
All SNPs considered for genotyping were previously associated
with HDL-C, LDL-C, and/or triglycerides in published (as of
2008) candidate gene and genome-wide association studies. A total
of 52 SNPs were targeted for genotyping by two or more PAGE
study sites. There is no overlap between samples used in this study
and samples used in GWAS from which the SNPs were selected.
The 52 targeted variants are located in or nearby 32 different
genes/gene regions, with 12 of the gene/gene regions represented
by two or more SNPs. Five SNPs are nonsynonymous, one SNP is
a nonsense variant, and two SNPs are synonymous; the remainder
are located in introns, flanking, or intergenic regions. The full list
of targeted SNPs, their locations, and their previously associated
lipid trait can be found in Table S2.
Cohorts and surveys were genotyped using either commercially
available genotyping arrays (Affymetrix 6.0, Illumina 370CNV
BeadChip), custom mid- and low-throughput assays (TaqMan,
Sequenom, Illumina GoldenGate or BeadXpress), or a combina-
tion thereof. Quality control was implemented at each study
site independently. In addition to site-specific quality control, all
PAGE study sites genotyped 360 DNA samples from the Inter-
national HapMap Project and submitted these data to the PAGE
Coordinating Center for concordance statistics [71]. Study specific
genotyping details are described in Text S1. Of the 52 targeted
SNPs, three (CETP rs1800775, APOE rs429358, and APOE rs7412)
failed at all PAGE study sites that attempted genotyping; therefore,
a total of 49 SNPs were tested in this analysis.
Statistical methods
All tests of association were performed by each PAGE study site
using the same analysis protocol prior to meta-analysis. The study
protocol excluded participants ,18 years of age as well as non-
fasting samples (defined here as ,8 hours). When triglyceride level
was the dependent variable, participants with .1,000 mg/dl were
excluded from analyses. Triglyceride (TG) levels were natural-log
transformed (ln) prior to analysis.
Linear regression was performed for fasting adults regardless
of lipid lowering medication use with HDL-C, LDL-C, or
ln(TG) as the dependent variable and a SNP as the independent
variable, assuming an additive genetic model, stratified by
race/ethnicity. The coded allele is reported in Table 2, Table 3,
Table 4. The beta estimate is per additional copy of the coded
allele. For each SNP, four models were considered: 1)
unadjusted, 2) adjusted for age (continuous in years) and sex,
3) adjusted for age, body mass index (continuous in kg/m
2),
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binary), post-menopausal status (yes/no for females only;
binary), and current hormone use (yes/no for females only;
binary), and 4) adjusted for age, body mass index, current
smoking, type 2 diabetes, post-menopausal status, current
hormone use, and previous myocardial infarction (yes/no;
binary). All PAGE study sites (except for WHI, which is female
only) stratified models 3 and 4 by sex given the sex-specific
variables (post-menopausal status and hormone use) prior to
meta-analysis. Select PAGE study sites also included study site
or site of ascertainment as a covariate in all models. Results
from Model 2 (adjusted for age and sex) are reported in the
main text while results from Models 1, 3, and 4 are presented in
Figures S4, S5, S6. Model 2 excluding participants on lipid-
lowering medications are presented in Figures S8, S9, S10.
Meta-analyses, using a fixed-effects inverse-variance weighted
approach and tests for effect size heterogeneity across studies, were
performed using METAL [72]. P-values were not adjusted for
multiple testing, and association results were plotted using Syn-
thesis-View [73,74], where indicated. Power calculations were
performed using Quanto [75,76] assuming unrelated participants,
an additive genetic model, the published effect size from Euro-
pean-descent populations listed in Table S1, and the population-
specific allele frequencies listed in Table 2, Table 3, Table 4.
Linkage disequilibrium was calculated using HapMap European
(CEU) and West African (YRI) data accessed through the Genome
Variation Server. FST was calculated using the Weir and Cocker-
ham algorithm [77]. Aggregate data from the meta-analysis as well
as individual tests of association from each PAGE study site will be
made available via dbGaP [30,78].
Web resources
NHGRI GWAS Catalog (www.genome.gov/GWAStudies).
Genome Variation Server (pga.gs.washington.edu).
Synthesis-View (http://chgr.mc.vanderbilt.edu/ritchielab/method.
php?method=synthesisview).
Supporting Information
Figure S1 Codedallelefrequency,bypopulation.Thecodedallele
frequency (CAF) is plotted for each of the 49 SNPs by population
using Synthesis-View [73,74]. The populations include European
Americans (EA), African Americans (AA), Mexican Americans/
Hispanics (MA/H), American Indians (AI), Japanese/East Asians (J/
EA), and Native Hawaiians/Pacific Islanders (NH/PI).
(DOCX)
Figure S2 Coded allele frequency across PAGE study sites, by
population. The coded allele frequency (CAF) is plotted for each of
the 49 SNPs by population using Synthesis-View [73,74]. The
studies include: Atherosclerosis Risk in Communities (ARIC),
Coronary Artery Risk in Young Adults (CARDIA), Cardiovascu-
lar Heart Study (CHS), Epidemiologic Architecture for Genes
Linked to Environment (EAGLE), Multiethnic Cohort (MEC),
Women’s Health Initiative (WHI), Strong Heart Community
Study (SHCS), and Strong Heart Family Study (SHFS) in Arizona
(AZ), Oklahoma (OK) and South Dakota (SD).
(DOCX)
Figure S3 Venn diagrams representing the overlap of significant
associations (p,0.05) across the four major PAGE populations
(European Americans, African Americans, Native Americans, and
Mexican Americans/Hispanics, for the three lipid traits (HDL-C,
LDL-C, and TG).
(DOCX)
Figure S4 Comparison of unadjusted, minimally adjusted,
adjusted models for HDL-C, by population. Results of tests of
association for four regression models are plotted: model 1
(unadjusted), model 2 (adjusted for age and sex; and site of
ascertainment for select PAGE studies), model 3 (adjusted for age,
sex, body mass index, current smoking, type 2 diabetes, post-
menopausal status, and current hormone use), and model 4 (model
3 with the addition of previous myocardial infarction). Each SNP
was tested for an association with HDL-C. Meta-analysis was
performed, and p-values (2log10 transformed) of the meta-analysis
are plotted along the y-axis. SNP location is given on the x-axis.
Each triangle represents a meta-analysis p-value for each popula-
tion. Models are color coded. Large triangles represent p-values at
or smaller than genome-wide significance (p,10
28). The direction
of the arrows corresponds to the direction of the beta coefficient.
The exact beta coefficients are reported on the bottom panel. The
significance threshold is indicated by the red bar at p=0.05.
(DOCX)
Figure S5 Comparison of unadjusted, minimally adjusted,
adjusted models for LDL-C, by population. Results of tests of
association for four regression models are plotted: model 1 (un-
adjusted), model 2 (adjusted for age and sex; and site of ascer-
tainment for select PAGE studies), model 3 (adjusted for age, sex,
body mass index, current smoking, type 2 diabetes, post-meno-
pausal status, and current hormone use), and model 4 (model 3 with
the addition of previous myocardial infarction). Each SNP was
testedfor an associationwith LDL-C. Meta-analysiswasperformed,
and p-values (2log10 transformed) of the meta-analysis are plotted
along the y-axis. SNP location is given on the x-axis. Each triangle
represents a meta-analysis p-value for each population. Models are
color coded. Large triangles represent p-values at or smaller than
genome-wide significance (p,10
28). The direction of the arrows
corresponds to the direction of the beta coefficient. The exact beta
coefficients are reported on the bottom panel. The significance
threshold is indicated by the red bar at p=0.05.
(DOCX)
Figure S6 Comparison of unadjusted, minimally adjusted,
adjusted models for triglyceride concentrations, by population.
Results of tests of association for four regression models are
plotted: model 1 (unadjusted), model 2 (adjusted for age and sex;
and site of ascertainment for select PAGE studies), model 3
(adjusted for age, sex, body mass index, current smoking, type 2
diabetes, post-menopausal status, and current hormone use), and
model 4 (model 3 with the addition of previous myocardial infarc-
tion). Each SNP was tested for an association with triglycerides.
Meta-analysis was performed, and p-values (–log10 transformed) of
the meta-analysis are plotted along the y-axis. SNP location is
given on the x-axis. Each triangle represents a meta-analysis p-
value for each population. Models are color coded. Large triangles
represent p-values at or smaller than genome-wide significance
(p,10
28). The direction of the arrows corresponds to the direction
of the beta coefficient. The exact beta coefficients are reported on
the bottom panel. The significance threshold is indicated by the
red bar at p=0.05.
(DOCX)
Figure S7 Comparison of genetic effect estimates when parti-
cipants are excluded or included based on medication use with
adjustments in WHI. Genetic effect estimates (b) and 95% confi-
dence interval are plotted for each SNP tested for an association.
The tests of association were performed on fasting European
Americans adjusted for age and sex and excluding participants on
lipid lowering medication (blue), including all participants
regardless of medication use (green), and all participants on lipid
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and ln(TG) effects estimated by Wu et al [87].
(DOCX)
Figure S8 HDL-C and the effects of lipid lowering medication
use on genetic associations, by population. Comparison of genetic
effects and significance when tests of association are performed
within fasting adults regardless of lipid lowering medication
(Include) versus fasting adults not on lipid lowering medication
(Exclude). All tests of association results shown here are minimally
adjusted for age and sex.
(DOCX)
Figure S9 LDL-C and the effects of lipid lowering medication
use on genetic associations, by population. Comparison of genetic
effects and significance when tests of association are performed
within fasting adults regardless of lipid lowering medication versus
fasting adults not on lipid lowering medication. All tests of asso-
ciation results shown here are minimally adjusted for age and sex.
(DOCX)
Figure S10 Transformed triglycerides and the effects of lipid
lowering medication use on genetic associations, by population.
Comparison of genetic effects and significance when tests of as-
sociation are performed within fasting adults regardless of lipid
lowering medication versus fasting adults not on lipid lowering
medication. All tests of association results shown here are mini-
mally adjusted for age and sex.
(DOCX)
Figure S11 Comparison of HDL-C associations across PAGE
study sites, by population. Results of tests of association for the
various PAGE study sites are plotted (where available) along with
meta-analysis results (META): Atherosclerosis Risk in Communi-
ties (ARIC), Coronary Artery Risk in Young Adults (CARDIA),
Cardiovascular Heart Study (CHS), Epidemiologic Architecture
for Genes Linked to Environment (EAGLE), Multiethnic Cohort
(MEC), Women’s Health Initiative (WHI), Strong Heart Com-
munity Study (SHCS), and Strong Heart Family Study (SHFS) in
Arizona(AZ), Oklahoma (OK) and South Dakota (SD). Each SNP
was tested for an association with HDL-C, adjusted for age and sex
(Model 2), including fasting adults on lipid lowering medications.
SNP location is given on the x-axis and p-values (2log10 trans-
formed) are plotted along the y-axis. Each triangle represents a
p-value for each PAGE study. PAGE study sites are color coded.
Large triangles represent p-values at or smaller than genome-wide
significance (p,10
28). The direction of the arrows corresponds to
the direction of the beta coefficient. The exact beta coefficients are
reported on the bottom panel. The significance threshold is indi-
cated by the red bar at p=0.05.
(DOCX)
Figure S12 Comparison of LDL-C associations across PAGE
study sites, by population. Results of tests of association for the
various PAGE study sites are plotted (where available) along with
meta-analysis results (META): Atherosclerosis Risk in Commu-
nities (ARIC), Coronary Artery Risk in Young Adults (CARDIA),
Cardiovascular Heart Study (CHS), Epidemiologic Architecture
for Genes Linked to Environment (EAGLE), Multiethnic Cohort
(MEC), Women’s Health Initiative (WHI), Strong Heart
Community Study (SHCS), and Strong Heart Family Study
(SHFS) in Arizona(AZ), Oklahoma (OK) and South Dakota (SD).
Each SNP was tested for an association with LDL-C levels,
adjusted for age and sex (Model 2), including fasting adults on
lipid lowering medications. SNP location is given on the x-axis
and p-values (2log10 transformed) are plotted along the y-axis.
Each triangle represents a p-value for each PAGE study. PAGE
study sites are color coded. Large triangles represent p-values
at or smaller than genome-wide significance (p,10
28). The
direction of the arrows corresponds to the direction of the beta
coefficient. The exact beta coefficients are reported on the
bottom panel. The significance threshold is indicated by the red
bar at p=0.05.
(DOCX)
Figure S13 Comparison transformed triglyceride associations
across PAGE study sites, by population. Results of tests of
association for the various PAGE study sites are plotted (where
available) along with meta-analysis results (META): Atherosclero-
sis Risk in Communities (ARIC), Coronary Artery Risk in Young
Adults (CARDIA), Cardiovascular Heart Study (CHS), Epidemi-
ologic Architecture for Genes Linked to Environment (EAGLE),
Multiethnic Cohort (MEC), Women’s Health Initiative (WHI),
Strong Heart Community Study (SHCS), and Strong Heart
Family Study (SHFS) in Arizona(AZ), Oklahoma (OK) and South
Dakota (SD). Each SNP was tested for an association with natural-
log transformed triglyceride levels, adjusted for age and sex (Model
2), including fasting adults on lipid lowering medications. SNP
location is given on the x-axis and p-values (-log10 transformed) are
plotted along the y-axis. Each triangle represents a p-value for
each PAGE study. PAGE study sites are color coded. Large
triangles represent p-values at or smaller than genome-wide sig-
nificance (p,10
28). The direction of the arrows corresponds to the
direction of the beta coefficient. The exact beta coefficients are
reported on the bottom panel. The significance threshold is indi-
cated by the red bar at p=0.05.
(DOCX)
Table S1 Study characteristics by PAGE study and population.
Descriptive statistics for fasting ($8 hours) adults ($18 years of
age) are expressed as percentage, median, and standard deviation
(SD) for each variable.
(DOCX)
Table S2 List of candidate gene and GWAS-identified SNPs
targeted for genotyping in PAGE. For each SNP (denoted by rs
number), we list the chromosomal and genomic location, the
putative function of the SNP (based on SNP location) and the
nearest gene, the number of PAGE studies that genotyped the
SNP, the trait associated with the SNP based on the literature, the
effect allele and effect size based on the literature, and the
reference for these data.
(DOC)
Text S1 Study descriptions.
(DOCX)
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